SCHEDULE: Gilde Healthcare Sells Shoulder Innovations Shares
Schedule 13D Amendment
Gilde Healthcare Holding B.V. and its affiliates have sold a substantial number of Shoulder Innovations, Inc. shares, reducing their beneficial ownership to 10.7%.
Summary
- Gilde Healthcare Holding B.V. and its affiliated entities have amended their Schedule 13D filing concerning Shoulder Innovations, Inc.
- As of May 6, 2026, there were 20,738,226 shares of Shoulder Innovations, Inc. Common Stock outstanding.
- Gilde Healthcare Holding B.V. is the record holder of 2,212,207 shares, representing approximately 10.7% of the outstanding shares.
- Due to management and ownership structures, Gilde Healthcare V Management B.V., Cooperatieve Gilde Healthcare V U.A., Manapouri B.V., and Martemanshurk B.V. may also be deemed beneficial owners of these shares.
- Over the past 60 days leading up to August 6, 2026, the reporting persons sold a total of 169,245 shares of Common Stock.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a negative sentiment due to significant share sales by a major holder, indicating potential lack of confidence or strategic shift.
Negatives
- Significant share sales by a major holder (Gilde Healthcare) over a short period.
- Total of 169,245 shares sold between July 30, 2026, and August 6, 2026.
- The sales occurred at prices generally ranging from $22.60 to $23.73 per share.
Risks
- Potential for further selling pressure if Gilde Healthcare continues to divest its stake.
- The substantial sales could be interpreted as a lack of confidence in the company's near-term prospects by a significant investor.
Future Outlook
No specific future outlook or guidance is provided in this amendment. The filing primarily details past transactions and current beneficial ownership.
Industry Context
StockSavvy.ai notes that significant selling by a major venture capital or private equity holder like Gilde Healthcare can signal a shift in investment strategy, a realization of gains, or a lack of conviction in future growth, which can impact market perception of Shoulder Innovations, Inc.
Stakeholder Impact
- Shareholders may experience downward pressure on stock price due to the large sell-off by a significant holder.
- Potential investors may view the sales as a negative signal, impacting future investment decisions.
Next Steps
- Monitor future filings from Gilde Healthcare and Shoulder Innovations, Inc. for any further changes in ownership or strategic direction.
- Observe market reaction to the significant share sales.
Key Dates
| Date | Description |
|---|---|
| 2025-08-05 | Original Schedule 13D filing date. |
| 2026-05-06 | Date as of which outstanding shares were reported in Issuer's Quarterly Report on Form 10-Q. |
| 2026-05-13 | Date of Issuer's Quarterly Report on Form 10-Q filing. |
| 2026-07-30 | Date of initial share sales reported in this amendment. |
| 2026-08-06 | Date of final share sale reported in this amendment. |
| 2026-08-07 | Date of signatures on the amendment. |
| 2026-08-05 | Date of Event Which Requires Filing of This Statement (as per cover page). |
Recommendation
holdThe significant selling by a major holder introduces uncertainty and potential negative price pressure. However, the filing does not provide information on the company's operational performance or future prospects, making a definitive 'sell' recommendation premature. A 'hold' position allows for further observation of the company's response and market reaction.
Keywords
Shoulder Innovations, Schedule 13D, Gilde Healthcare, Shareholder, Beneficial Ownership, Stock Sale, Investment Fund
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.